Induced pluripotent stem (iPS) cells: A new source for cell-based therapeutics?

Journal of Controlled Release

Volumn 185, Issue 1, 2014, Pages 37-44

  De Lázaro, Irene ^a   Yilmazer, Açelya ^a,b   Kostarelos, Kostas ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Cell replacement therapy; Pluripotency; Regenerative medicine; Reprogramming

Indexed keywords

REGENERATIVE MEDICINE; STEM CELLS;

CELL REPLACEMENT THERAPY; ECTOPIC EXPRESSIONS; EPIGENETIC MEMORY; GENOMIC INSTABILITY; PLURIPOTENCY; REPLACEMENT STRATEGY; REPROGRAMMING; THERAPEUTIC APPLICATION;

CYTOLOGY;

KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MICRORNA; NAKED DNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VIRUS VECTOR;

ARTICLE; BLASTOCYST; BLOOD; CELL COUNT; CELL DIFFERENTIATION; CELL THERAPY; CELL TRACKING; CLINICAL STUDY; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; ENDODERM; FOLLOW UP; GENE EXPRESSION; GENE TRANSFER; GENOMIC INSTABILITY; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; KERATINOCYTE; LIVER CELL; MESODERM; MONONUCLEAR CELL; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTO ONCOGENE; REGENERATIVE MEDICINE; SINGLE CELL ANALYSIS; SKIN BIOPSY; SOMATIC CELL; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; UMBILICAL CORD BLOOD; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; METABOLISM; NUCLEAR REPROGRAMMING; PROCEDURES; TRANSPLANTATION;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; CELLULAR REPROGRAMMING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 84900453177     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.04.011     Document Type: Review

References (120)

1. K.K. Mallick, and S.C. Cox Biomaterial scaffolds for tissue engineering Front. Biosci. (Elite Ed) 5 2013 341 360
2. D. Ilic, and J.M. Polak Stem cells in regenerative medicine: introduction Br. Med. Bull. 98 2011 117 126
3. L.A. Fortier Stem cells: classifications, controversies, and clinical applications Vet. Surg. 34 2005 415 423 (Pubitemid 41718170)
4. D.G. Phinney, and D.J. Prockop Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views Stem Cells 25 2007 2896 2902 (Pubitemid 350127874)
5. C.V. Alvarez, M. Garcia-Lavandeira, M.E. Garcia-Rendueles, E. Diaz-Rodriguez, A.R. Garcia-Rendueles, S. Perez-Romero, T.V. Vila, J.S. Rodrigues, P.V. Lear, and S.B. Bravo Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells J. Mol. Endocrinol. 49 2012 R89 R111
6. K. English, and K.J. Wood Immunogenicity of embryonic stem cell-derived progenitors after transplantation Curr. Opin. Organ Transplant 16 2011 90 95
7. I. Wilmut Consternation and confusion following EU patent judgment Cell Stem Cell 9 2011 498 499
8. V. Volarevic, B. Ljujic, P. Stojkovic, A. Lukic, N. Arsenijevic, and M. Stojkovic Human stem cell research and regenerative medicine - present and future Br. Med. Bull. 99 2011 155 168
9. A. Abbott Italian stem-cell trial based on flawed data Nature News 2013 (http://www.nature.com/news/italian-stem-cell-trial-based-on-flawed-data-1. 13329)
10. A. Abbott Italian court rules science advisers unlawful Nature News 2014 (http://www.nature.com/news/italian-court-rules-science-advisers-unlawful-1. 14307)
11. A. Abbott Leaked files slam stem-cell therapy Nature 505 2014 139 140
12. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676 (Pubitemid 44233629)
13. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872 (Pubitemid 350138099)
14. A. Abbott Cell rewind wins medicine Nobel Nature 490 2012 151 152
15. K. Okita, T. Ichisaka, and S. Yamanaka Generation of germline-competent induced pluripotent stem cells Nature 448 2007 313 317 (Pubitemid 47080336)
16. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, R. Stewart, I.I. Slukvin, and J.A. Thomson Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
17. M. Nakagawa, M. Koyanagi, K. Tanabe, K. Takahashi, T. Ichisaka, T. Aoi, K. Okita, Y. Mochiduki, N. Takizawa, and S. Yamanaka Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nat. Biotechnol. 26 2008 101 106
18. N. Montserrat, E. Nivet, I. Sancho-Martinez, T. Hishida, S. Kumar, L. Miquel, C. Cortina, Y. Hishida, Y. Xia, C.R. Esteban, and J.C. Belmonte Reprogramming of human fibroblasts to pluripotency with lineage specifiers Cell Stem Cell 13 2013 341 350
19. W.E. Lowry, L. Richter, R. Yachechko, A.D. Pyle, J. Tchieu, R. Sridharan, A.T. Clark, and K. Plath Generation of human induced pluripotent stem cells from dermal fibroblasts Proc. Natl. Acad. Sci. U. S. A. 105 2008 2883 2888 (Pubitemid 351723638)
20. Y.S. Chun, P. Chaudhari, and Y.Y. Jang Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease Int. J. Biol. Sci. 6 2010 796 805
21. K. Okita, T. Yamakawa, Y. Matsumura, Y. Sato, N. Amano, A. Watanabe, N. Goshima, and S. Yamanaka An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells Stem Cells 31 2013 458 466
22. Y.H. Loh, S. Agarwal, I.H. Park, A. Urbach, H. Huo, G.C. Heffner, K. Kim, J.D. Miller, K. Ng, and G.Q. Daley Generation of induced pluripotent stem cells from human blood Blood 113 2009 5476 5479
23. J. Staerk, M.M. Dawlaty, Q. Gao, D. Maetzel, J. Hanna, C.A. Sommer, G. Mostoslavsky, and R. Jaenisch Reprogramming of human peripheral blood cells to induced pluripotent stem cells Cell Stem Cell 7 2010 20 24
24. X.B. Zhang Cellular reprogramming of human peripheral blood cells Genomics Proteomics Bioinformatics 11 2013 264 274
25. F. Gonzalez, S. Boue, and J.C. Izpisua Belmonte Methods for making induced pluripotent stem cells: reprogramming a la carte Nat. Rev. Genet. 12 2011 231 242
26. C.A. Sommer, M. Stadtfeld, G.J. Murphy, K. Hochedlinger, D.N. Kotton, and G. Mostoslavsky Induced pluripotent stem cell generation using a single lentiviral stem cell cassette Stem Cells 27 2009 543 549
27. B. Hamilton, Q. Feng, M. Ye, and G.G. Welstead Generation of induced pluripotent stem cells by reprogramming mouse embryonic fibroblasts with a four transcription factor, doxycycline inducible lentiviral transduction system J. Vis. Exp. 13 2009
28. C.A. Sommer, A.G. Sommer, T.A. Longmire, C. Christodoulou, D.D. Thomas, M. Gostissa, F.W. Alt, G.J. Murphy, D.N. Kotton, and G. Mostoslavsky Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector Stem Cells 28 2010 64 74
29. K. Tashiro Optimization of adenovirus vectors for transduction in embryonic stem cells and induced pluripotent stem cells Yakugaku Zasshi 131 2011 1333 1338
30. N. Fusaki, H. Ban, A. Nishiyama, K. Saeki, and M. Hasegawa Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85 2009 348 362
31. K. Woltjen, I.P. Michael, P. Mohseni, R. Desai, M. Mileikovsky, R. Hamalainen, R. Cowling, W. Wang, P. Liu, M. Gertsenstein, K. Kaji, H.K. Sung, and A. Nagy piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells Nature 458 2009 766 770
32. K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka Generation of mouse induced pluripotent stem cells without viral vectors Science 322 2008 949 953
33. K. Okita, H. Hong, K. Takahashi, and S. Yamanaka Generation of mouse-induced pluripotent stem cells with plasmid vectors Nat. Protoc. 5 2010 418 428
34. K. Okita, Y. Matsumura, Y. Sato, A. Okada, A. Morizane, S. Okamoto, H. Hong, M. Nakagawa, K. Tanabe, K. Tezuka, T. Shibata, T. Kunisada, M. Takahashi, J. Takahashi, H. Saji, and S. Yamanaka A more efficient method to generate integration-free human iPS cells Nat. Methods 8 2011 409 412
35. J. Yu, K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I.I. Slukvin, and J.A. Thomson Human induced pluripotent stem cells free of vector and transgene sequences Science 324 2009 797 801
36. M. Li, I. Sancho-Martinez, and J.C. Izpisua Belmonte Cell fate conversion by mRNA Stem Cell Res. Ther. 2 2011 5
37. F. Anokye-Danso, C.M. Trivedi, D. Juhr, M. Gupta, Z. Cui, Y. Tian, Y. Zhang, W. Yang, P.J. Gruber, J.A. Epstein, and E.E. Morrisey Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency Cell Stem Cell 8 2011 376 388
38. D. Kim, C.H. Kim, J.I. Moon, Y.G. Chung, M.Y. Chang, B.S. Han, S. Ko, E. Yang, K.Y. Cha, R. Lanza, and K.S. Kim Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins Cell Stem Cell 4 2009 472 476
39. K. Plath, and W.E. Lowry Progress in understanding reprogramming to the induced pluripotent state Nat. Rev. Genet. 12 2011 253 265
40. Y. Buganim, Dina A. Faddah, Albert W. Cheng, E. Itskovich, S. Markoulaki, K. Ganz, Sandy L. Klemm, A. van Oudenaarden, and R. Jaenisch Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase Cell 150 2012 1209 1222
41. Jose M. Polo, E. Anderssen, Ryan M. Walsh, Benjamin A. Schwarz, Christian M. Nefzger, Sue M. Lim, M. Borkent, E. Apostolou, S. Alaei, J. Cloutier, O. Bar-Nur, S. Cheloufi, M. Stadtfeld, Maria E. Figueroa, D. Robinton, S. Natesan, A. Melnick, J. Zhu, S. Ramaswamy, and K. Hochedlinger A molecular roadmap of reprogramming somatic cells into iPS cells Cell 151 2012 1617 1632
42. Y. Rais, A. Zviran, S. Geula, O. Gafni, E. Chomsky, S. Viukov, A.A. Mansour, I. Caspi, V. Krupalnik, M. Zerbib, I. Maza, N. Mor, D. Baran, L. Weinberger, D.A. Jaitin, D. Lara-Astiaso, R. Blecher-Gonen, Z. Shipony, Z. Mukamel, T. Hagai, S. Gilad, D. Amann-Zalcenstein, A. Tanay, I. Amit, N. Novershtern, and J.H. Hanna Deterministic direct reprogramming of somatic cells to pluripotency Nature 502 2013 65 70
43. R. Jaenisch, and R. Young Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming Cell 132 2008 567 582 (Pubitemid 351253686)
44. I.H. Park, N. Arora, H. Huo, N. Maherali, T. Ahfeldt, A. Shimamura, M.W. Lensch, C. Cowan, K. Hochedlinger, and G.Q. Daley Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
45. Y. Maury, M. Gauthier, M. Peschanski, and C. Martinat Human pluripotent stem cells for disease modelling and drug screening Bioessays 34 2011 61 71
46. F.T. Merkle, and K. Eggan Modeling human disease with pluripotent stem cells: from genome association to function Cell Stem Cell 12 2013 656 668
47. M. Bellin, M.C. Marchetto, F.H. Gage, and C.L. Mummery Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13 2012 713 726
48. D. Ma, H. Wei, Y. Zhao, J. Lu, G. Li, N.B. Sahib, T.H. Tan, K.Y. Wong, W. Shim, P. Wong, S.A. Cook, and R. Liew Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells Int. J. Cardiol. 168 2013 5277 5286
49. M.A. Israel, S.H. Yuan, C. Bardy, S.M. Reyna, Y. Mu, C. Herrera, M.P. Hefferan, S. Van Gorp, K.L. Nazor, F.S. Boscolo, C.T. Carson, L.C. Laurent, M. Marsala, F.H. Gage, A.M. Remes, E.H. Koo, and L.S. Goldstein Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells Nature 482 2012 216 220
50. A. Eigentler, S. Boesch, R. Schneider, G. Dechant, and R. Nat Induced pluripotent stem cells from Friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons Stem Cells Dev. 22 2013 3271 3282
51. J. Du, E. Campau, E. Soragni, C. Jespersen, and J.M. Gottesfeld Length-dependent CTG. CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells Hum. Mol. Genet. 22 2013 5276 5287
52. G.H. Liu, B.Z. Barkho, S. Ruiz, D. Diep, J. Qu, S.L. Yang, A.D. Panopoulos, K. Suzuki, L. Kurian, C. Walsh, J. Thompson, S. Boue, H.L. Fung, I. Sancho-Martinez, K. Zhang, J. Yates 3rd, and J.C. Izpisua Belmonte Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome Nature 472 2011 221 225
53. J. Zhang, Q. Lian, G. Zhu, F. Zhou, L. Sui, C. Tan, R.A. Mutalif, R. Navasankari, Y. Zhang, H.F. Tse, C.L. Stewart, and A. Colman A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects Cell Stem Cell 8 2011 31 45
54. S. Agarwal, Y.H. Loh, E.M. McLoughlin, J. Huang, I.H. Park, J.D. Miller, H. Huo, M. Okuka, R.M. Dos Reis, S. Loewer, H.H. Ng, D.L. Keefe, F.D. Goldman, A.J. Klingelhutz, L. Liu, and G.Q. Daley Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients Nature 464 2010 292 296
55. D.M. Gamm, M.J. Phillips, and R. Singh Modeling retinal degenerative diseases with human iPS-derived cells: current status and future implications Expert Rev. Ophthalmol. 8 2013 213 216
56. A.C. O'Neill, and S.D. Ricardo Human kidney cell reprogramming: applications for disease modeling and personalized medicine J. Am. Soc. Nephrol. 24 2013 1347 1356
57. N. Egawa, S. Kitaoka, K. Tsukita, M. Naitoh, K. Takahashi, T. Yamamoto, F. Adachi, T. Kondo, K. Okita, I. Asaka, T. Aoi, A. Watanabe, Y. Yamada, A. Morizane, J. Takahashi, T. Ayaki, H. Ito, K. Yoshikawa, S. Yamawaki, S. Suzuki, D. Watanabe, H. Hioki, T. Kaneko, K. Makioka, K. Okamoto, H. Takuma, A. Tamaoka, K. Hasegawa, T. Nonaka, M. Hasegawa, A. Kawata, M. Yoshida, T. Nakahata, R. Takahashi, M.C.N. Marchetto, F.H. Gage, S. Yamanaka, and H. Inoue Drug screening for ALS using patient-specific induced pluripotent stem cells Sci. Transl. Med. 4 2012 (145ra104)
58. G. Lee, C.N. Ramirez, H. Kim, N. Zeltner, B. Liu, C. Radu, B. Bhinder, Y.J. Kim, I.Y. Choi, B. Mukherjee-Clavin, H. Djaballah, and L. Studer Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression Nat. Biotechnol. 30 2012 1244 1248
59. I. Espuny-Camacho, K.A. Michelsen, D. Gall, D. Linaro, A. Hasche, J. Bonnefont, C. Bali, D. Orduz, A. Bilheu, A. Herpoel, N. Lambert, N. Gaspard, S. Peron, S.N. Schiffmann, M. Giugliano, A. Gaillard, and P. Vanderhaeghen Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo Neuron 77 2013 440 456
60. K. Takahashi, and S. Yamanaka Induced pluripotent stem cells in medicine and biology Development 140 2013 2457 2461
61. J. Sng, and T. Lufkin Emerging stem cell therapies: treatment, safety, and biology Stem Cells Int. 2012 2012 521343
62. D. Cyranoski iPS cells in humans Nat. Biotechnol. 31 2013 775
63. S. Yamanaka A fresh look at iPS cells Cell 137 2009 13 17
64. M.J. Evans, and M.H. Kaufman Establishment in culture of pluripotential cells from mouse embryos Nature 292 1981 154 156 (Pubitemid 11050741)
65. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, and J.M. Jones Embryonic stem cell lines derived from human blastocysts Science 282 1998 1145 1147 (Pubitemid 28516247)
66. D.C. Wu, A.S. Boyd, and K.J. Wood Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack Stem Cells 26 2008 1939 1950
67. R.J. Swijnenburg, S. Schrepfer, F. Cao, J.I. Pearl, X. Xie, A.J. Connolly, R.C. Robbins, and J.C. Wu In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation Stem Cells Dev. 17 2008 1023 1029
68. J.D. Ebben, M. Zorniak, P.A. Clark, and J.S. Kuo Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine World Neurosurg. 76 2011 270 275
69. T. Zhao, Z.N. Zhang, Z. Rong, and Y. Xu Immunogenicity of induced pluripotent stem cells Nature 474 2011 212 215
70. F.J. Muller, J. Goldmann, P. Loser, and J.F. Loring A call to standardize teratoma assays used to define human pluripotent cell lines Cell Stem Cell 6 2010 412 414
71. P. Guha, J.W. Morgan, G. Mostoslavsky, N.P. Rodrigues, and A.S. Boyd Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells Cell Stem Cell 12 2013 407 412
72. R. Araki, M. Uda, Y. Hoki, M. Sunayama, M. Nakamura, S. Ando, M. Sugiura, H. Ideno, A. Shimada, A. Nifuji, and M. Abe Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells Nature 494 2013 100 104
73. S. Kaneko, and S. Yamanaka To be immunogenic, or not to be: that's the iPSC question Cell Stem Cell 12 2013 385 386
74. M. Wernig, J.P. Zhao, J. Pruszak, E. Hedlund, D. Fu, F. Soldner, V. Broccoli, M. Constantine-Paton, O. Isacson, and R. Jaenisch Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 105 2008 5856 5861 (Pubitemid 351758462)
75. Y. Li, Y.T. Tsai, C.W. Hsu, D. Erol, J. Yang, W.H. Wu, R.J. Davis, D. Egli, and S.H. Tsang Long-term safety and efficacy of human induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa Mol. Med. 18 2012 1312 1319
76. C.H. Yoo, H.J. Na, D.S. Lee, S.C. Heo, Y. An, J. Cha, C. Choi, J.H. Kim, J.C. Park, and Y.S. Cho Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases Biomaterials 34 2013 8149 8160
77. M.C. Puri, and A. Nagy Concise review: embryonic stem cells versus induced pluripotent stem cells: the game is on Stem Cells 30 2012 10 14
78. J. Bilic, and J.C. Izpisua Belmonte Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells 30 2012 33 41
79. J. Hanna, M. Wernig, S. Markoulaki, C.W. Sun, A. Meissner, J.P. Cassady, C. Beard, T. Brambrink, L.C. Wu, T.M. Townes, and R. Jaenisch Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin Science 318 2007 1920 1923
80. G. Hargus, O. Cooper, M. Deleidi, A. Levy, K. Lee, E. Marlow, A. Yow, F. Soldner, D. Hockemeyer, P.J. Hallett, T. Osborn, R. Jaenisch, and O. Isacson Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats Proc. Natl. Acad. Sci. U. S. A. 107 2010 15921 15926
81. S. Nori, Y. Okada, A. Yasuda, O. Tsuji, Y. Takahashi, Y. Kobayashi, K. Fujiyoshi, M. Koike, Y. Uchiyama, E. Ikeda, Y. Toyama, S. Yamanaka, M. Nakamura, and H. Okano Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice Proc. Natl. Acad. Sci. U. S. A. 108 2011 16825 16830
82. I.H. Park DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy Mol. Ther. 18 2010 238 240
83. A. Filareto, S. Parker, R. Darabi, L. Borges, M. Iacovino, T. Schaaf, T. Mayerhofer, J.S. Chamberlain, J.M. Ervasti, R.S. McIvor, M. Kyba, and R.C. Perlingeiro An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells Nat. Commun. 4 2013 1549
84. H. Liu, Y. Kim, S. Sharkis, L. Marchionni, and Y.Y. Jang In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins Sci. Transl. Med. 3 2011 (82ra39)
85. Y.H. Rhee, J.Y. Ko, M.Y. Chang, S.H. Yi, D. Kim, C.H. Kim, J.W. Shim, A.Y. Jo, B.W. Kim, H. Lee, S.H. Lee, W. Suh, C.H. Park, H.C. Koh, Y.S. Lee, R. Lanza, and K.S. Kim Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease J. Clin. Invest. 121 2011 2326 2335
86. H. Kawai, T. Yamashita, Y. Ohta, K. Deguchi, S. Nagotani, X. Zhang, Y. Ikeda, T. Matsuura, and K. Abe Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain J. Cereb. Blood Flow Metab. 30 2010 1487 1493
87. M.B. Jensen, H. Yan, R. Krishnaney-Davison, A. Al Sawaf, and S.C. Zhang Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model J. Stroke Cerebrovasc. Dis. 22 2013 304 308
88. K. Oki, J. Tatarishvili, J. Wood, P. Koch, S. Wattananit, Y. Mine, E. Monni, D. Tornero, H. Ahlenius, J. Ladewig, O. Brustle, O. Lindvall, and Z. Kokaia Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain Stem Cells 30 2012 1120 1133
89. A. Swistowski, J. Peng, Q. Liu, P. Mali, M.S. Rao, L. Cheng, and X. Zeng Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions Stem Cells 28 2010 1893 1904
90. J. Polentes, P. Jendelova, M. Cailleret, H. Braun, N. Romanyuk, P. Tropel, M. Brenot, V. Itier, C. Seminatore, K. Baldauf, K. Turnovcova, D. Jirak, M. Teletin, J. Come, J. Tournois, K. Reymann, E. Sykova, S. Viville, and B. Onteniente Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain Cell Transplant. 21 2012 2587 2602
91. J. Qin, B. Song, H. Zhang, Y. Wang, N. Wang, Y. Ji, J. Qi, A. Chandra, B. Yang, Y. Zhang, G. Gong, and Y. Xu Transplantation of human neuro-epithelial-like stem cells derived from induced pluripotent stem cells improves neurological function in rats with experimental intracerebral hemorrhage Neurosci. Lett. 548 2013 95 100
92. H. Suzuki, R. Shibata, T. Kito, M. Ishii, P. Li, T. Yoshikai, N. Nishio, S. Ito, Y. Numaguchi, J.K. Yamashita, T. Murohara, and K. Isobe Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells BMC Cell Biol. 11 2010 72
93. Q. Lian, Y. Zhang, J. Zhang, H.K. Zhang, X. Wu, F.F. Lam, S. Kang, J.C. Xia, W.H. Lai, K.W. Au, Y.Y. Chow, C.W. Siu, C.N. Lee, and H.F. Tse Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice Circulation 121 2010 1113 1123
94. T.J. Nelson, A. Martinez-Fernandez, S. Yamada, C. Perez-Terzic, Y. Ikeda, and A. Terzic Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells Circulation 120 2009 408 416
95. K. Homma, S. Okamoto, M. Mandai, N. Gotoh, H.K. Rajasimha, Y.S. Chang, S. Chen, W. Li, T. Cogliati, A. Swaroop, and M. Takahashi Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptors Stem Cells 31 2013 1149 1159
96. D. Cyranoski Japan's stimulus package showers science with cash Nature 493 2013 465
97. P.P. Song, Y. Inagaki, Y. Sugawara, and N. Kokudo Perspectives on human clinical trials of therapies using iPS cells in Japan: Reaching the forefront of stem-cell therapies Biosci. Trends 7 2013 157 158
98. Y. Hirami, F. Osakada, K. Takahashi, K. Okita, S. Yamanaka, H. Ikeda, N. Yoshimura, and M. Takahashi Generation of retinal cells from mouse and human induced pluripotent stem cells Neurosci. Lett. 458 2009 126 131
99. D. Cyranoski Stem cells cruise to clinic Nature 494 2013 413
100. A.M. Tetsuhiro Kikuchi, Daisuke Doi, Hirotaka Onoe, Hayashi Takuya, Toshiyuki Kawasaki, Hidemoto Saiki, Susumu Miyamoto, and Jun Takahashi Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease J. Park. Dis. 1 2011 395 412
101. D. Cyranoski Stem-cell pioneer banks on future therapies Nature 488 2012 139
102. G. Tavernier, B. Mlody, J. Demeester, J. Adjaye, and S.C. De Smedt Current methods for inducing pluripotency in somatic cells Adv. Mater. 25 2013 2765 2771
103. D.A. Robinton, and G.Q. Daley The promise of induced pluripotent stem cells in research and therapy Nature 481 2012 295 305
104. S.M. Hussein, N.N. Batada, S. Vuoristo, R.W. Ching, R. Autio, E. Narva, S. Ng, M. Sourour, R. Hamalainen, C. Olsson, K. Lundin, M. Mikkola, R. Trokovic, M. Peitz, O. Brustle, D.P. Bazett-Jones, K. Alitalo, R. Lahesmaa, A. Nagy, and T. Otonkoski Copy number variation and selection during reprogramming to pluripotency Nature 471 2011 58 62
105. R. Lister, M. Pelizzola, Y.S. Kida, R.D. Hawkins, J.R. Nery, G. Hon, J. Antosiewicz-Bourget, R. O'Malley, R. Castanon, S. Klugman, M. Downes, R. Yu, R. Stewart, B. Ren, J.A. Thomson, R.M. Evans, and J.R. Ecker Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells Nature 471 2011 68 73
106. A. Gore, Z. Li, H.L. Fung, J.E. Young, S. Agarwal, J. Antosiewicz-Bourget, I. Canto, A. Giorgetti, M.A. Israel, E. Kiskinis, J.H. Lee, Y.H. Loh, P.D. Manos, N. Montserrat, A.D. Panopoulos, S. Ruiz, M.L. Wilbert, J. Yu, E.F. Kirkness, J.C. Izpisua Belmonte, D.J. Rossi, J.A. Thomson, K. Eggan, G.Q. Daley, L.S. Goldstein, and K. Zhang Somatic coding mutations in human induced pluripotent stem cells Nature 471 2011 63 67
107. K. Miura, Y. Okada, T. Aoi, A. Okada, K. Takahashi, K. Okita, M. Nakagawa, M. Koyanagi, K. Tanabe, M. Ohnuki, D. Ogawa, E. Ikeda, H. Okano, and S. Yamanaka Variation in the safety of induced pluripotent stem cell lines Nat. Biotechnol. 27 2009 743 745
108. B.A. Tucker, K.R. Anfinson, R.F. Mullins, E.M. Stone, and M.J. Young Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation Stem Cells Transl. Med. 2 2013 16 24
109. G. Chen, D.R. Gulbranson, Z. Hou, J.M. Bolin, V. Ruotti, M.D. Probasco, K. Smuga-Otto, S.E. Howden, N.R. Diol, N.E. Propson, R. Wagner, G.O. Lee, J. Antosiewicz-Bourget, J.M. Teng, and J.A. Thomson Chemically defined conditions for human iPSC derivation and culture Nat. Methods 8 2011 424 429
110. K. Rajala, B. Lindroos, S.M. Hussein, R.S. Lappalainen, M. Pekkanen-Mattila, J. Inzunza, B. Rozell, S. Miettinen, S. Narkilahti, E. Kerkela, K. Aalto-Setala, T. Otonkoski, R. Suuronen, O. Hovatta, and H. Skottman A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells PLoS One 5 2010 e10246
111. S. Asgari, M. Moslem, K. Bagheri-Lankarani, B. Pournasr, M. Miryounesi, and H. Baharvand Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells Stem Cell Rev. 9 2013 493 504
112. G.J. Sullivan, Y. Bai, J. Fletcher, and I. Wilmut Induced pluripotent stem cells: epigenetic memories and practical implications Mol. Hum. Reprod. 16 2010 880 885
113. B. Papp, and K. Plath Epigenetics of reprogramming to induced pluripotency Cell 152 2013 1324 1343
114. W.E. Lowry, and W.L. Quan Roadblocks en route to the clinical application of induced pluripotent stem cells J. Cell Sci. 123 2010 643 651
115. F. Nakajima, K. Tokunaga, and N. Nakatsuji Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy Stem Cells 25 2007 983 985 (Pubitemid 46572595)
116. C.J. Taylor, S. Peacock, A.N. Chaudhry, J.A. Bradley, and E.M. Bolton Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types Cell Stem Cell 11 2012 147 152
117. A. Yilmazer, I. de Lazaro, C. Bussy, and K. Kostarelos In vivo cell reprogramming towards pluripotency by virus-free overexpression of defined factors PLoS One 8 2013 e54754
118. A. Yilmazer, I. de Lazaro, C. Bussy, and K. Kostarelos In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors JoVE 17 2013
119. M. Abad, L. Mosteiro, C. Pantoja, M. Canamero, T. Rayon, I. Ors, O. Grana, D. Megias, O. Dominguez, D. Martinez, M. Manzanares, S. Ortega, and M. Serrano Reprogramming in vivo produces teratomas and iPS cells with totipotency features Nature 502 2013 340 345
120. K. Ohnishi, K. Semi, T. Yamamoto, M. Shimizu, A. Tanaka, K. Mitsunaga, K. Okita, K. Osafune, Y. Arioka, T. Maeda, H. Soejima, H. Moriwaki, S. Yamanaka, K. Woltjen, and Y. Yamada Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation Cell 156 2014 663 677